| Ytd | 52.21% | |
| 1y | -33.45% |
| Open | 0.97 | Prev Close | 0.96 | Low | 0.96 | High | 1.01 | Mkt Cap | 46.90M |
| Vol | 1.23M | Avg Vol | 7.01M | EPS | -0.73 | P/E | N/A | Forward P/E | -0.86 |
| Beta | 0.41 | Short Ratio | 2.09 | Inst. Own | 72.62% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 10-30 | 50-d Avg | 0.62 | 200-d Avg | 0.65 | 1yr Est | 12.00 |
Gainers Werewolf Therapeutics (NASDAQ:HOWL) shares increased by 108.1% to $0.9 during Friday's
Dow gains 400 points, Materials sector up 2.3%, Werewolf Therapeutics up 113%, S&P PMI rises to
US stocks rise, Dow gains over 350 points as markets open Friday; Materials sector up 2%, utilitie
Werewolf Therapeutics and Ambros Therapeutics merge in an all-stock deal with $150M in financing to
Werewolf Therapeutics surged after announcing a $500 million merger with Ambros Therapeutics, puttin
Gainers Werewolf Therapeutics (NASDAQ:HOWL) shares moved upwards by 74.6% to $0.75 during Friday
Ross Stores beats estimates with Q2 financial results, shares jump 9.1%. Other gainers include RFAI,